![]()
|
||
|
||
|
The subject of adhesive arachnoiditis as a disease entity has been, and continues to be a most serious global health care problem. It is evident to me, as a physician and surgeon who has been intimately involved in studying, publishing, lecturing and treating patients with this disease for over 25 years that there has been a serious failure, in the past, by the medical, scientific and governmental professions to focus appropriate attention on this important entity.
The subarachnoid space represents the most fragile, pristine, and sensitive structure in the human body. The introduction of foreign body substances, for any purpose, is not without patient risk.
All foreign bodies
are irritating to the arachnoid membranes. Some substances such as
oil-based myelographic media and steroid preparations containing
ethylene glycols are known to be particularly irritating and toxic and
capable of producing disability and incapacitation.
From my personal
observations, over the past 25 years, it is evident that many
patients with adhesive arachnoiditis have severe scarring of their
nerves without associated clinical signs or symptoms. In fact the great
majority of patients with adhesive arachnoiditis due to oil myelography
are asymptomatic because of the slow progression of the inflammatory
process. The opposite is typically true for those who have adhesive arachnoiditis
due to the ill-advised deposition of ethylene glycol steroids into the
subarachnoid space typically for the purpose of “epidural” steroid
administration.
The failure to appreciate adhesive arachnoiditis as a disease entity has come back to haunt the public through the inordinately common use of ill-advised “epidural” steroid injections with suspensions containing ethylene glycol. Epidural steroid injection is an overused therapy. When performed in the absence of fluoroscopic monitoring with epidurography this procedure the procedure is dangerous. When performed by well-trained procedurist, associated with informed consent, good technique and basically non-toxic steroids it is a reasonable invasive therapy; after quality non-invasive therapy has failed.
Charles V. Burton,
M.D., F.A.C.S.
November 29, 2003 |
||
|
||
|
||
|
M.K., shown above in 2003, has been disabled since she had a pantopaque
myelogram in 1977. Following the introduction of the oil media
multiple dural punctures were made in an attempt to remove all of the
pantopaque. In this process M.S. was tipped head down and oil
entered the subarachnoid space at the base of the brain. M.S.
developed adhesive arachnoiditis producing back and leg pain as well as
headache. The disability experienced was of such a degree that a
depth brain neurostimulating system was implanted in 1978 for pain
control. The case presented above is typical of situations where multiple dural punctures added free blood to the oil dye increasing the toxic inflammatory response. The understanding of this is important in the continuing need to prevent clinically significant adhesive arachnoiditis in patients who have placed their trust in their physicians. |
||
|
|
||
|
|
||
|
|